SCHEMBL5773797

SCHEMBL5773797

Cc1nc(NCCN2CCOCC2)c2[nH]c(C)cc2n1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 1/20 0.72
HSD17B10 Q99714 6/20 0.49
USP2 O75604 3/20 0.49
TP53 P04637 1/20 0.49
GLA P06280 1/20 0.49
CYP3A4 P08684 6/20 0.49
KDM4E B2RXH2 2/20 0.47
GAA P10253 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
CYP1A2 P05177 3/20 0.47
CYP2D6 P10635 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
EGFR P00533 1/20 0.46
TSHR P16473 2/20 0.46
LMNA P02545 2/20 0.45
CHRM1 P11229 1/20 0.45
CNR1 P21554 1/20 0.45
ACHE P22303 1/20 0.45
HTR2B P41595 1/20 0.45
KCNH2 Q12809 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7185038 0.84 NPY5R (1.00) NPY5RHSD17B10USP2TP53GLA
SCHEMBL5775706 0.71 NPY5R (0.74) NPY5R
SCHEMBL5773802 0.69 NPY5R (0.49) NPY5RHSD17B10GLACYP3A4KDM4E
SCHEMBL19398329 0.68 CYP3A4 (0.56) NPY5RHSD17B10USP2TP53GLA
SCHEMBL27171011 0.68 NPY5R (0.53) NPY5RHSD17B10USP2TP53GLA
Water SCHEMBL10568867 0.68 KDM4E (0.52) NPY5RHSD17B10USP2GLACYP3A4
SCHEMBL10671611 0.67 CYP3A4 (0.47) NPY5RHSD17B10USP2TP53GLA
SCHEMBL27171000 0.66 EGFR (0.49) NPY5RHSD17B10USP2TP53GLA
Hydrochloric Acid SCHEMBL10664815 0.66 HSD17B10 (0.46) NPY5RHSD17B10USP2TP53GLA
SCHEMBL18511634 0.66 TLR7 (0.51) NPY5RHSD17B10USP2TP53GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed